 NEW YORK and SCOTTSDALE, Ariz., Oct. 05, 2021 GLOBE NEWSWIRE -- Journey Medical Corporation Journey Medical, a partner company of Fortress Biotech, Inc. NASDAQ: FBIO Fortress focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products, today announces the appointment of Ernest De Paolantonio as Chief Financial Officer, effective September 30, 2021. 